Fidelity Advisor Health Care Z (FIKCX)

Fund Assets	3.34B
Expense Ratio	0.56%
Min. Investment	$0.00
Turnover	52.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 26, 2025

Previous Close	77.20
YTD Return	17.95%
1-Year Return	33.99%
5-Year Return	12.91%
52-Week Low	58.80
52-Week High	79.02
Beta (5Y)	n/a
Holdings	155
Inception Date	Oct 2, 2018

About FIKCX

Fidelity Advisor Health Care Fund Class Z is an actively managed mutual fund specializing in the health care sector. The fund's primary objective is capital appreciation, and it achieves this by investing at least 80% of its assets in the securities of companies that are principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. This includes businesses across various subsectors such as pharmaceuticals, biotechnology, medical equipment, and health care services. Established in 2018, the fund is managed by Fidelity, a leading provider of investment management services. The portfolio typically consists of a diversified selection of growth and value stocks, and as of the latest available data, it holds over 100 different positions within the health care industry. The fund is notable for its relatively low expense ratio in its class, making it a cost-effective choice for investors seeking exposure to health care equities. With assets totaling several billion dollars, it plays a significant role for investors aiming to capture growth opportunities in one of the most dynamic and essential sectors of the global economy.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: FIKCX
• Share Class: Class Z
• Index: S&P 500 TR

Performance

FIKCX had a total return of 33.99% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.73%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FHCIX	Class I	0.68%
FACDX	Class A	0.93%
FACTX	Class M	1.18%
FHCCX	Class C	1.68%

Top 10 Holdings

40.48% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	7.66%
Danaher Corporation	DHR	6.75%
Thermo Fisher Scientific Inc.	TMO	6.31%
UnitedHealth Group Incorporated	UNH	4.17%
Johnson & Johnson	JNJ	3.78%
AbbVie Inc.	ABBV	3.62%
argenx SE	ARGX	2.09%
Merck & Co., Inc.	MRK	2.09%
West Pharmaceutical Services, Inc.	WST	2.06%
Ascendis Pharma A/S	ASND	1.95%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$7.462	Dec 29, 2025
Dec 26, 2024	$6.856	Dec 27, 2024
Dec 17, 2021	$4.207	Dec 20, 2021
Dec 18, 2020	$4.091	Dec 21, 2020
Dec 20, 2019	$0.374	Dec 23, 2019
Dec 7, 2018	$2.218	Dec 10, 2018

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 9, 2026

Data Sources Report a data error